Stéphanie Val

Senior Scientist - T cell process development at TCR2 Therapeutics - Cambridge, MA, US

Stéphanie Val's Contact Details
HQ
617-949-5200
Location
Cambridge, Massachusetts, United States
Company
TCR2 Therapeutics
Stéphanie Val's Company Details
TCR2 Therapeutics logo, TCR2 Therapeutics contact details

TCR2 Therapeutics

Cambridge, MA, US • 250 - 499 Employees
BioTech/Drugs

TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.

Cancer therapy T cell biology Immunology Molecular biology Biotech Biotech
Details about TCR2 Therapeutics
Frequently Asked Questions about Stéphanie Val
Stéphanie Val currently works for TCR2 Therapeutics.
Stéphanie Val's role at TCR2 Therapeutics is Senior Scientist - T cell process development.
Stéphanie Val's email address is ***@tcr2.com. To view Stéphanie Val's full email address, please signup to ConnectPlex.
Stéphanie Val works in the BioTech/Drugs industry.
Stéphanie Val's colleagues at TCR2 Therapeutics are Esteban Enrique, Alec Andrews, Jing Qiu, Michelle Azaroff, Dhanashree Vispute, Bingtao Tang, Kristen DeFrancisco and others.
Stéphanie Val's phone number is 617-949-5200
See more information about Stéphanie Val